Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling

Jörgen Åstrand; Anna Kajsa Harding; Per Aspenberg; Magnus Tägil

doi:10.1186/1471-2474-7-63

Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling

Jörgen Åstrand, Anna Kajsa Harding, Per Aspenberg, Magnus Tägil

Orthopaedics (Lund)

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	BMC Musculoskeletal Disorders
Volume	63
Issue number	7
DOIs	https://doi.org/10.1186/1471-2474-7-63
Publication status	Published - 2006

Subject classification (UKÄ)

Orthopedics

Access to Document

10.1186/1471-2474-7-63

1 Doctoral Thesis (compilation)

Pharmacological manipulation of fracture healing and bone remodeling
Harding, A. K., 2010, Department of Orthopaedics, Lund University. 94 p.
Research output: Thesis › Doctoral Thesis (compilation)

File

Cite this

@article{12761b23899c4865a196f2dc5c647b3c,

title = "Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling",

author = "J{\"o}rgen {\AA}strand and Harding, {Anna Kajsa} and Per Aspenberg and Magnus T{\"a}gil",

year = "2006",

doi = "10.1186/1471-2474-7-63",

language = "English",

volume = "63",

journal = "BMC Musculoskeletal Disorders",

issn = "1471-2474",

publisher = "BioMed Central (BMC)",

number = "7",

}

TY - JOUR

T1 - Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling

AU - Åstrand, Jörgen

AU - Harding, Anna Kajsa

AU - Aspenberg, Per

AU - Tägil, Magnus

PY - 2006

Y1 - 2006

U2 - 10.1186/1471-2474-7-63

DO - 10.1186/1471-2474-7-63

M3 - Article

SN - 1471-2474

VL - 63

JO - BMC Musculoskeletal Disorders

JF - BMC Musculoskeletal Disorders

IS - 7

ER -

Systemic zoledronate treatment both prevents resorption of allograft bone and increases the retention of new formed bone during revascularization and remodelling

Subject classification (UKÄ)

Access to Document

Research output

Pharmacological manipulation of fracture healing and bone remodeling

Cite this